RRx-001 (Oncology infusion formulation for Epicent Rx)

Vanton developed the formulation and Conduct the stability study. It is currently in Phase 2 open label trial.

The work includes:

epicent rx logo

Vanton Labs can help you move your product development forward.

Copyright © 2015, Vanton Research Laboratory, LLC. All rights reserved.